Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference111 articles.
1. Worldwide access to treatment for end-stage kidney disease: a systematic review;Liyanage;Lancet,2015
2. Global variation in renal replacement therapy for end-stage renal disease;Caskey;Nephrol Dial Transplant,2011
3. Conservative care in Europe–nephrologists' experience with the decision not to start renal replacement therapy;van de Luijtgaarden;Nephrol Dial Transplant,2013
Cited by 279 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. CD73 as a T cell dysfunction marker predicting cardiovascular and infection events in patients undergoing hemodialysis;Clinica Chimica Acta;2024-03
2. Effects of CYP3A4*22 and POR*28 variations on the pharmacokinetics of tacrolimus in renal transplant recipients: a meta-analysis of 18 observational studies;BMC Nephrology;2024-02-06
3. Percutaneous Coronary Intervention With a Drug-Eluting Stent Versus Coronary Artery Bypass Grafting in Patients Receiving Dialysis: A National Study From Taiwan;Kidney Medicine;2024-02
4. Prevalence of restless legs syndrome in maintenance hemodialysis patients: A systematic review and meta-analysis;Sleep Medicine;2024-02
5. Poor limb prognosis of patients with chronic limb-threatening ischemia on hemodialysis: A retrospective observational study based on the Global Limb Anatomic Staging System (GLASS);Annals of Vascular Surgery;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3